Loading clinical trials...
Loading clinical trials...
A Randomized Open-Label Trial of CONvalenscent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness (CONCOR-1)
Conditions
Interventions
Convalescent plasma
Locations
73
United States
Brooklyn Hospital
Brooklyn, New York, United States
Lower Manhattan Hospital
New York, New York, United States
Weill Cornell Medical Center
New York, New York, United States
Hospital Universitário Antônio Pedro (HUAP)
Niterói, Brazil
Hemario
Rio de Janeiro, Brazil
Peter Lougheed Center
Calgary, Alberta, Canada
Start Date
March 14, 2020
Primary Completion Date
March 5, 2021
Completion Date
June 16, 2021
Last Updated
March 3, 2022
NCT06631287
NCT05101213
NCT04565665
NCT06871293
NCT04978571
NCT06082518
Lead Sponsor
Hamilton Health Sciences Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions